RECORD OF PROCEEDINGS
PHYSICAL DISABILITY BOARD OF REVIEW
BRANCH OF SERVICE: MARINE CORPS
SEPARATION DATE: 20021130
NAME: XXXX
CASE NUMBER: PD1200464
BOARD DATE: 20121031
SUMMARY OF CASE: Data extracted from the available evidence of record reflects that this
covered individual (CI) was a Reserve LCPL/E-3 (Food Service Specialist, 3381), medically
separated for folliculitis decalvans (FD). The CI was initially diagnosed with FD in 2001, treated
by dermatology with shampoo, topical cream, anti-inflammatory and antibiotic medications.
He did not improve adequately to perform his Military Occupational Specialty (MOS) in full
capacity. He was unable to comply with military grooming regulations, was not worldwide
assignable, and referred for a Medical Evaluation Board (MEB). The MEB forwarded no other
conditions for Physical Evaluation Board (PEB) adjudication. The PEB adjudicated the FD
condition as unfitting, rated 10%, with application of the Veteran’s Affairs Schedule for Rating
Disabilities (VASRD). The CI made no appeals, and was medically separated with a 10%
disability rating.
CI CONTENTION: “My disability (service-connected), folliculitis decalvans, has no known cure.
Therefore,
incurable disability/disorder.
(continued) At the time of my disability separation it was stated that scars on my scalp had let
to bleeding over my pillowcase. It has been nearly a decade since this, and yet I still experience
bleeding (occasionally) over my pillowcase. As mentioned on the first page (item 3) I still take
medications to try to minimize scalp inflammation.
SCOPE OF REVIEW: The Board wishes to clarify that the scope of its review as defined in the
Department of Defense Instruction (DoDI) 6040.44, Enclosure 3, paragraph 5.e.(2) is limited to
those conditions which were determined by the PEB to be specifically unfitting for continued
military service; or, when requested by the CI, those condition(s) “identified but not
determined to be unfitting by the PEB.” The ratings for unfitting conditions will be reviewed in
all cases. The FD condition requested for consideration meets the criteria prescribed in DoDI
6040.44 for Board purview, and is accordingly addressed below. Any condition or contention
not requested in this application, or otherwise outside the Board’s defined scope of review,
remain eligible for future consideration by Board for Correction of Naval Records.
RATING COMPARISON:
I am continuously taking medication for this
VA (~6 Mos. Post-Separation) – All Effective Date 20021201
Rating
10%
Condition
Folliculitis Decalvans
No Additional VA Entries
Code
7899-7806
Rating
10%*
Exam
20030630
20030630
Folliculitis Decalvans
Service IPEB – Dated 20021002
Condition
Code
7899-7806
No Additional MEB/PEB Entries
Combined: 10%
*No subsequent VARDs
ANALYSIS SUMMARY: IAW DoDI 6040.44, the Board’s authority is limited to making
recommendations on correcting disability determinations. The Board’s role is thus confined to
the review of medical records and all evidence at hand to assess the fairness of PEB rating
Combined: 10%
that
indicated
determinations, compared to VASRD standards, based on ratable severity at the time of
separation; and, to review those fitness determinations within its scope (as elaborated above)
based on MOS performance limitations in evidence at separation. (NOTE: The VASRD changes
for disability codes 7806-7819, effective August 30, 2002, were applicable in this case and the
changes for codes 7800-7805, effective October 23, 2008, were not applicable.) The Board
acknowledges the CI’s information regarding the significant impairment with which his service-
connected condition continue to burden him; but, must emphasize that the Disability
Evaluation System (DES) has neither the role nor the authority to compensate members for
anticipated future severity or potential complications of conditions resulting in medical
separation. That role and authority is granted by Congress to the Department of Veterans’
Affairs (DVA), operating under a different set of laws. Post-separation evidence is probative to
the Board’s recommendations only to the extent that it reasonably reflects the disability at the
time of separation.
Folliculitis Decalvans Condition. The CI’s scalp condition appeared following the CI’s initial
haircut at boot camp. He developed papulo-pustular lesions on the scalp with some keloid
formation to the neck and scalp area. Topical therapy and systemic antibiotic therapy did not
resolve the scalp lesions and the CI was subsequently diagnosed with FD. He was unable to
tolerate close haircuts or wear a helmet. The MEB physical exam performed approximately 8
months prior to separation, noted scalp lesions described as “erythematous pustules in a
folliculocentric pattern on his scalp and several boggy plaques as well as plaques of scarred
alopecia. Purulent discharge was easily expressed from the boggy plaques with pressure.”
Treatment notes
the CI was not on systemic corticosteroids or
immunosuppressive medications. The bleeding from his scalp lesions led to duty restrictions.
The VA Compensation and Pension (C&P) exam performed approximately 6 months after
separation indicated a similar history as the service record. Exam demonstrated “the patient's
hair is coarse thoroughly. Follicular papules are visually appreciated and palpated over the
entirety of the patient's scalp. No pustules are present today. There are few scattered foci of
scarring alopecia.” The examiner indicated photographs were not obtained because the CI was
wearing his hair long that prevented an accurate photograph of what was palpated. The
examiner diagnosed “Folliculitis decalvans (100% of scalp).”
The Board directs attention to its rating recommendation based on the above evidence. Both
the PEB and VA rated this condition analogously to 7806 (Dermatitis or eczema) at 10%. The CI
had not been on “systemic therapy such as corticosteroids or other immunosuppressive drugs”
and the remainders of the 7806 rating criteria are based on the area of skin involved. The CI
had been on systemic antibiotics, which the Board adjudged was not considered equivalent to
systemic therapy such as “as corticosteroids or other immunosuppressive drugs.” Codes 7800
(Disfigurement of the head, face, or neck) and 7830 (Scarring alopecia) were considered for
potential alternative coding. The Board noted that there was apparent improvement in the CI’s
scalp condition from the MEB exam to the VA rating exam. Neither exam provided specific
equivalent square inches involved and/or specific measurements for plaques or scars. Although
“Folliculitis decalvans (100% of scalp)” was the VA exam diagnosis, this was interpreted to mean
there was no sparing of the scalp from the follicular papules. Papules, by definition have
normal surrounding skin that would not be counted for the affected square area and surface
area determinations. There was some doubt that the MEB exam may have approached the
20% of exposed skin criteria for rating at 30% IAW VASRD 7806; however, the VA exam was
adjudged as below 20% of the exposed area affected (10% rating level). The Board consensus
was that less than 20% of the exposed areas were affected at the time of separation. There
was insufficient evidence for higher rating using alternative coding under 7800 (disfigurement
of the head, face, or neck), or under 7830 Scarring alopecia. After due deliberation, considering
all of the evidence and mindful of VASRD §4.3 (reasonable doubt), the Board concluded that
2 PD1200464
there was insufficient cause to recommend a change in the PEB adjudication for the folliculitis
decalvans condition.
BOARD FINDINGS: IAW DoDI 6040.44, provisions of DoD or Military Department regulations or
guidelines relied upon by the PEB will not be considered by the Board to the extent they were
inconsistent with the VASRD in effect at the time of the adjudication. The Board did not
surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD
were exercised. In the matter of the folliculitis decalvans condition and IAW VASRD §4.118, the
Board unanimously recommends no change in the PEB adjudication. There were no other
conditions within the Board’s scope of review for consideration.
RECOMMENDATION: The Board, therefore, recommends that there be no recharacterization of
the CI’s disability and separation determination, as follows:
VASRD CODE RATING
7899-7806
COMBINED
10%
10%
Folliculitis Decalvans
UNFITTING CONDITION
The following documentary evidence was considered:
Exhibit A. DD Form 294, dated 20120602, w/atchs
Exhibit B. Service Treatment Record
Exhibit C. Department of Veterans’ Affairs Treatment Record
XXXX
President
Physical Disability Board of Review
3 PD1200464
MEMORANDUM FOR DIRECTOR, SECRETARY OF THE NAVY COUNCIL
OF REVIEW BOARDS
Subj: PHYSICAL DISABILITY BOARD OF REVIEW (PDBR) RECOMMENDATIONS
Ref: (a) DoDI 6040.44
(b) CORB ltr dtd 7 Nov 12
In accordance with reference (a), I have reviewed the cases forwarded by reference (b), and, for
the reasons provided in their forwarding memorandum, approve the recommendations of the PDBR
that the following individual’s records not be corrected to reflect a change in either characterization
of separation or in the disability rating previously assigned by the Department of the Navy’s
Physical Evaluation Board:
- former USN
- former USN
- former USMC
- former USN
- former USMC
- former USMC
- former USMC
- former USN
Assistant General Counsel
(Manpower & Reserve Affairs)
4 PD1200464
AF | PDBR | CY2010 | PD2010-00997
The Board’s role is confined to the review of medical records and all evidence at hand to assess the fairness of PEB rating determinations, compared to VASRD standards, based on severity at the time of separation. Regardless of the criteria used, the IPEB rating is consistent with the VA rating at 10% nearly two years after separation, and code 7820 does allow rating under code 7806, used by the VA and supporting a 10% rating. After careful consideration of all available evidence the Board...
AF | PDBR | CY2014 | PD-2014-02255
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the Veterans Affairs Schedule for Rating Disabilities (VASRD) standards to the unfitting medical condition at the time of separation. The CI ultimately responded to a 10-day, followed by a 21-day, taper of decreasing doses of oral steroids.A subsequent dermatology consultation from March 2008 (8 months prior to separation) described the previous...
AF | PDBR | CY2013 | PD-2013-02232
The MEB characterized the CI’s skin condition as “solar urticaria” (a condition in which exposure to the sun [or ultraviolet radiation] induces urticaria or hives)and forwarded this to the Physical Evaluation Board (PEB) for consideration. The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the Veterans Affairs Schedule for Rating Disabilities (VASRD) standards to the unfitting medical condition at...
AF | PDBR | CY2013 | PD-2013-01281
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of theVeterans Affairs Schedule for Rating Disabilities (VASRD) standards to the unfitting medical condition at the time of separation. The first note in the treatment record dated 9 September 2000 indicated the CI had an 8-year history of discoid lupus and not systemic lupus erythematosus. Additionally, there were annotations that the diagnosis of...
AF | PDBR | CY2011 | PD2011-01091
The PEB adjudicated the bilateral plantar fasciitis with underlying pes planus condition, and recurrent skin abscesses condition as unfitting, rated 0% and 0% respectively, with application of the Veterans Administration Schedule for Rating Disabilities (VASRD). The left knee osteochondral defect and left ankle sprain conditions requested for consideration and the unfitting plantar fasciitis and recurrent skin abscesses conditions meet the criteria prescribed in DoDI 6040.44 for Board...
AF | PDBR | CY2013 | PD-2013-01795
The CI reported flares of the skin with sun exposure only. The diagnosis was atopic (allergic rhinitis) and the examiner opined that increased temperature (rather than sunlight or ultraviolet radiation caused the rash.At a VA dermatology evaluation on 30 September 2004,a month after separation, the CI was using vitamin E lotion only, having “tried and failed”multiple treatments including oral steroids, steroid creams, antihistamines, animmunosuppressant skin cream (Elidel), and “light box...
AF | PDBR | CY2013 | PD-2013-02746
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of theVASRD standards to the unfitting medical condition at the time of separation. The CI reported that she was on methotrexate until February 2007 and then switched to oral retinoid therapy, which is not corroboratedby the service medical records.The Board also considered that the evidence at the after separation C&P was in conflict with a note in the...
AF | PDBR | CY2014 | PD-2014-00468
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the Veterans Affairs Schedule for Rating Disabilities (VASRD) standards to the unfitting medical condition at the time of separation. The Board did not surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD were exercised.In the matter of the psoriasis (skin condition) and IAW VASRD §4.118, the Board unanimously...
AF | PDBR | CY2009 | PD2009-00068
RECOMMENDATIONS: Sergeant B---'s current medical condition of chronic psoriasis precludes him from continuation on active duty; and he is, therefore, going to be referred to the Physical Evaluation Board for further evaluation and disposition. No other medical conditions were documented; REVIEW OF SYSTEMS: Musculoskeletal - the patient complains of chronic knee pain. Other Conditions.
AF | PDBR | CY2014 | PD-2014-03167
The C&P exam noted the CI was treated for contact dermatitis for less than 6 weeks within the past 12 months with a topical corticosteroid cream. BOARD FINDINGS : The Board did not surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD were exercised.In the matter of the contact dermatitis to hydraulic fluids condition and IAW VASRD §4.118 (Schedule of Ratings –Skin), the Board unanimously recommends no change in the PEB adjudication.There were no other...